Parissa Tabrizian, MD Email Parissa Tabrizian
- ASSISTANT PROFESSOR | Surgery
- Hospital Affiliation
- The Mount Sinai Hospital
Parissa Tabrizian, MD, MSc is a board-certified surgeon who specializes in hepatobiliary and liver transplantation at the Recanati/Miller Transplantation Institute. She is an assistant professor of surgery at the Mount Sinai School of Medicine. Dr. Tabrizian earned her medical degree at the University of Vienna medical school and completed her general surgery residency at the Mount Sinai Medical Center in New York. She completed fellowships in surgical oncology and multiorgan transplant surgery at Mount Sinai Hospital.
In 2015, Dr. Tabrizian obtained a master’s degree in clinical research from the Icahn School of Medicine, New York.
Dr. Tabrizian performs a wide range of both open and advanced laparoscopic procedures. Her research interests include hepatocellular carcinoma (liver cancer), cholangiocarcinoma (bile duct cancer), and liver transplantation.
American Board of Surgery
- Gallbladder Cancer
- Liver Cancer
- Liver Transplant
- Pancreatic Cancer
Cancer, Liver, Transplantation
MD, University of Vienna - Austria
MSc, Icahn School of Medicine
Mount Sinai School of Medicine
Fellowship, Surgical Oncology
Mount Sinai Hospital
Fellowship, Transplant Surgery
Mount Sinai Hospital
IME House Staff Excellence in Teaching Award
Arthur Aufses Junior Prize in Surgery/Excellence in Teaching
Alpha Omega Alpha
Alpha Omega Alpha Honor Medical Society
Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, Schwartz M, Han G, Izzo F, Chen M, Blanc JF, Johnson P, Kudo M, Roberts LR, Sherman M. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology (Baltimore, Md.) 2015 Aug; 62(2).
Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Annals of surgery 2015 May; 261(5).
Franssen B, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S, Schwartz ME. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Annals of surgery 2014 Oct; 260(4).
Tabrizian P, Jibara G, Hechtman JF, Franssen B, Labow DM, Schwartz ME, Thung SN, Sarpel U. Outcomes following resection of intrahepatic cholangiocarcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association 2015 Apr; 17(4).
D'Amico F, Schwartz M, Vitale A, Tabrizian P, Roayaie S, Thung S, Guido M, del Rio Martin J, Schiano T, Cillo U. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009 Oct; 15(10).
Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World journal of gastroenterology 2014 Aug; 20(30).
Tabrizian P, Jibara G, Shrager B, Schwartz ME, Roayaie S. Hepatic resection for primary hepatolithiasis: a single-center Western experience. Journal of the American College of Surgeons 2012 Nov; 215(5).
Shrager B, Jibara GA, Tabrizian P, Roayaie S, Ward SC. Resection of nonalcoholic steatohepatitis-associated hepatocellular carcinoma: a Western experience. International journal of surgical oncology 2012; 2012.
Sogawa H, Shrager B, Jibara G, Tabrizian P, Roayaie S, Schwartz M. Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB : the official journal of the International Hepato Pancreato Biliary Association 2013 Feb; 15(2).
Franssen B, Jibara G, Tabrizian P, Schwartz ME, Roayaie S. Actual 10-year survival following hepatectomy for hepatocellular carcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association 2014 Sep; 16(9).
Yang T, Tabrizian P, Zhang H, Lau WY, Han J, Li ZL, Wang Z, Wu MC, Florman S, Schwartz ME, Shen F. Comparison of Patterns and Outcomes of Liver Resection for Hepatocellular Carcinoma: East vs West. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017 Dec; 15(12).
Tabrizian P, Joseph TT, Radkani P, Cohen E, Facciuto M. Liver Transplantation in an Adult Recipient With Situs Inversus Totalis: Case Report and Review of the Literature. Transplantation proceedings 2016 Nov; 48(9).
Kim S, Zerillo J, Tabrizian P, Wax D, Lin HM, Evans A, Florman S, DeMaria S. Postoperative Meld-Lactate and Isolated Lactate Values As Outcome Predictors Following Orthotopic Liver Transplantation. Shock (Augusta, Ga.) 2017 Jul; 48(1).
Tabrizian P, Midulla PS. Laparoscopic excision of a large hepatic cyst. JSLS : Journal of the Society of Laparoendoscopic Surgeons; 14(2).
Shrager B, Jibara GA, Tabrizian P, Schwartz ME, Labow DM, Hiotis S. Resection of large hepatocellular carcinoma (≥10 cm): a unique western perspective. Journal of surgical oncology 2013 Feb; 107(2).
Tabrizian P, Jibara G, Shrager B, Elsabbagh AM, Roayaie S, Schwartz ME. Diaphragmatic hernia after hepatic resection: case series at a single Western institution. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2012 Oct; 16(10).
Tabrizian P, Sweeney RE, Uhr JH, Nguyen SQ, Divino CM. Laparoscopic resection of gastric and small bowel gastrointestinal stromal tumors: 10-year experience at a single center. Journal of the American College of Surgeons 2014 Mar; 218(3).
Tabrizian P, Berger Y, Pierobon ES, Aycart S, Argiriadi P, Fei K, Carrasco-Avino G, Labow DM, Sarpel U. Are Clinical Guidelines for the Management of Intraductal Papillary Mucinous Neoplasms Followed?: A Single-Center Analysis. Pancreas 2017 Feb; 46(2).
Tabrizian P, Franssen B, Jibara G, Sweeney R, Sarpel U, Schwartz M, Labow D. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma. Journal of surgical oncology 2014 Dec; 110(7).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Tabrizian has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.